Trials / Sponsors / NextCure, Inc.
NextCure, Inc.
Industry · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-02-26 |
| Recruiting | A Phase 1 Study of LNCB74 in Advanced Solid Tumors Ovarian Cancer, Breast Cancer, Endometrial Cancer | Phase 1 | 2025-01-07 |
| Terminated | A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory Myelodysplastic Syndrome | Phase 1 | 2023-02-28 |
| Active Not Recruiting | A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectab Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High | Phase 1 / Phase 2 | 2022-10-06 |
| Withdrawn | A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metast Advanced or Metastatic Solid Tumors, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-12-06 |
| Terminated | A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors, Ovarian Cancer, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-06-30 |
| Terminated | A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors, Ovarian Cancer, Gastric Cancer | Phase 1 / Phase 2 | 2020-06-10 |
| Completed | A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer | Phase 1 / Phase 2 | 2018-10-01 |